Search research articles
Contact Us
Filters
Showing results (191-200 of 262) with videos related to
Page
of 27
Sort By:
Seminars in Arthritis and Rheumatism
|
April 29, 2018
The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis
Adam Schiffenbauer, Sara Faghihi-Kashani, Terrence P O'Hanlon, et al.
Arthritis and Rheumatism
|
November 6, 2012
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial
Chester V Oddis, Ann M Reed, Rohit Aggarwal, et al.
RMD Open
|
November 28, 2024
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease
Sangmee Sharon Bae, Fereidoun Abtin, Grace Kim, et al.
Clinical and Experimental Rheumatology
|
March 4, 2024
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review
Didem Saygin, Stefanie Glaubitz, Rachel Zeng, et al.
Autoimmunity Reviews
|
July 16, 2025
Remission and low disease activity definitions in adult idiopathic inflammatory myopathies: A narrative review by myositis clinical trials consortium (MCTC)
Nantakarn Pongtarakulpanit, Shiri Keret, Vaidehi Kothari, et al.
Clinical and Experimental Rheumatology
|
February 25, 2026
Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials
Daphne Rivero Gallegos, Faye M Pais, Ting-Yuan Lan, et al.
Rheumatology (Oxford, England)
|
April 24, 2025
Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD)
Rohit Aggarwal, Nantakarn Pongtarakulpanit, Daniel I Sullivan, et al.
Rheumatology (Oxford, England)
|
March 17, 2023
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles
Didem Saygin, Hanna Kim, Christian Douglas, et al.
Rheumatology International
|
March 12, 2024
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study
Cristiana Sieiro Santos, Jun-Peng Chen, Elena Nikiphorou, et al.
Rheumatology (Oxford, England)
|
February 18, 2021
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies
Alexander G S Oldroyd, Andrew B Allard, Jeffrey P Callen, et al.
Page
of 27
Search research articles
Search
Showing results (191-200 of 262) with videos related to
Sort By:
Page
of 27
Seminars in Arthritis and Rheumatism
|
April 29, 2018
The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositis
Adam Schiffenbauer, Sara Faghihi-Kashani, Terrence P O'Hanlon, et al.
Arthritis and Rheumatism
|
November 6, 2012
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial
Chester V Oddis, Ann M Reed, Rohit Aggarwal, et al.
RMD Open
|
November 28, 2024
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease
Sangmee Sharon Bae, Fereidoun Abtin, Grace Kim, et al.
Clinical and Experimental Rheumatology
|
March 4, 2024
Performance of the 2017 EULAR/ACR Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a scoping review
Didem Saygin, Stefanie Glaubitz, Rachel Zeng, et al.
Autoimmunity Reviews
|
July 16, 2025
Remission and low disease activity definitions in adult idiopathic inflammatory myopathies: A narrative review by myositis clinical trials consortium (MCTC)
Nantakarn Pongtarakulpanit, Shiri Keret, Vaidehi Kothari, et al.
Clinical and Experimental Rheumatology
|
February 25, 2026
Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials
Daphne Rivero Gallegos, Faye M Pais, Ting-Yuan Lan, et al.
Rheumatology (Oxford, England)
|
April 24, 2025
Abatacept for the treatment of myositis-associated interstitial lung disease (ATtackMy-ILD)
Rohit Aggarwal, Nantakarn Pongtarakulpanit, Daniel I Sullivan, et al.
Rheumatology (Oxford, England)
|
March 17, 2023
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profiles
Didem Saygin, Hanna Kim, Christian Douglas, et al.
Rheumatology International
|
March 12, 2024
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study
Cristiana Sieiro Santos, Jun-Peng Chen, Elena Nikiphorou, et al.
Rheumatology (Oxford, England)
|
February 18, 2021
A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies
Alexander G S Oldroyd, Andrew B Allard, Jeffrey P Callen, et al.
Page
of 27